Video Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara CertaraMarch 27, 2025
Exploring Common CDISC ADaM Conformance Findings Blog Exploring Common CDISC ADaM Conformance Findings March 27, 2025 ADaM data are required by the FDA and PMDA and accepted by…CertaraMarch 27, 2025
Video Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development CertaraMarch 26, 2025
Introducing the new Certara.com: Transforming drug development for good, together. Blog Introducing the new Certara.com: Transforming drug development for good, together. March 26, 2025 We’re thrilled to introduce the launch of our revamped website and refreshed…CertaraMarch 26, 2025
QSP Modeling Optimizes FIH Dose Selection for Multiple Myeloma Therapy Case Study QSP Modeling Optimizes FIH Dose Selection for Multiple Myeloma Therapy Multiple myeloma, the second most common blood cancer, affects an estimated 160,000 individuals annually worldwide…CertaraMarch 25, 2025
Quantitative systems pharmacology model of mRNA lipid nanoparticle for two programs at the preclinical to clinical transition Case Study Quantitative systems pharmacology model of mRNA lipid nanoparticle for two programs at the preclinical to clinical transition This case study features Applied BioMath's* collaboration with Alexion Pharmaceuticals. Alexion Pharmaceuticals, Inc. is a…CertaraMarch 25, 2025
Centers of Excellence in Pharma: Driving Efficiency and Innovation Blog Centers of Excellence in Pharma: Driving Efficiency and Innovation March 25, 2025 In today's fast-paced pharmaceutical industry, Centers of Excellence (CoEs) have become vital…CertaraMarch 25, 2025